New EMA Guideline on Environmental Risk Assessment for Human Medicinal Products
- Home
- regulatory updates
- New EMA Guideline on Environmental Risk Assessment for Human Medicinal Products
New EMA Guideline on Environmental Risk Assessment for Human Medicinal Products
Tuesday, 23 April 2024
María José Villarroel, Toxicology & Quality Director
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
New guideline from the European Medicines Agency (EMA) on the Environmental Risk Assessment of medicinal products for human use, accepted on February 15 and set to come into effect on September 1, 2024, stipulates that an ERA report will be required for all new applications for marketing authorization of medicinal products for human use.
%20on%20the%20Environmental%20Risk%20Assessment%20of%20medicinal%20products%20for%20human%20use.png?width=2048&height=1536&name=New%20guideline%20from%20the%20European%20Medicines%20Agency%20(EMA)%20on%20the%20Environmental%20Risk%20Assessment%20of%20medicinal%20products%20for%20human%20use.png)
EMA – Guideline on the Enviromental Risk Assessment of medicinal products for human use
In an increasingly environmentally conscious world, it is crucial to ensure that the drugs we consume do not pose a threat to our environment. This is where Environmental Risk Assessment (ERA) comes into play.
ERA is a fundamental process in the pharmaceutical industry involving a series of studies and scientific analyses aimed at identifying and quantifying the potential adverse effects that drugs may have on aquatic and terrestrial environments. These studies include toxicological tests, biodegradability studies, drug metabolism analysis, and assessment of their presence in different environmental compartments.
The new guideline from the European Medicines Agency (EMA), accepted on February 15 and set to come into effect on September 1, 2024, stipulates that an ERA report will be required for all new applications for marketing authorization of medicinal products for human use.
If you need assistance in preparing ERA reports to tackle current and future toxicological challenges, thereby ensuring the safety of your drugs and environmental responsibility, feel free to contact our team of toxicology experts certified by AETOX and EUROTOX.
Discover more expert content
Previous
Quality Assurance
27 Jan 2025
New revision to EMA Guidance documents released
Both documents, Guidance on the procedural aspects for the consultation to the European Medicines...
Quality Assurance
9 Jul 2024
New Update of Appendix 1 of the Nitrosamines Guideline
What’s new? In this update, the Acceptable Intake (AI) values for nitrosamines related to the use...
Quality Assurance
2 Jun 2025
Nitrosamines Update EMA/409815/2020 Rev.22
What is new?
Quality Assurance
4 Dec 2025
New Update of Appendix 1 of the Nitrosamines Guideline - EMA/42261/2025/Rev. 11
What's new? This update introduces the Acceptable Intake (AI) values for new nitrosamine drug...
Quality Assurance
18 Sep 2024
The FDA releases revision of guidance regarding Control of Nitrosamine Impurities in Human Drugs
What’s new?
Quality Assurance
27 Jan 2025
New revision to EMA Guidance documents released
Both documents, Guidance on the procedural aspects for the consultation to the European Medicines...
Quality Assurance
9 Jul 2024
New Update of Appendix 1 of the Nitrosamines Guideline
What’s new? In this update, the Acceptable Intake (AI) values for nitrosamines related to the use...
Quality Assurance
2 Jun 2025
Nitrosamines Update EMA/409815/2020 Rev.22
What is new?
Quality Assurance
4 Dec 2025
New Update of Appendix 1 of the Nitrosamines Guideline - EMA/42261/2025/Rev. 11
What's new? This update introduces the Acceptable Intake (AI) values for new nitrosamine drug...
Quality Assurance
18 Sep 2024
The FDA releases revision of guidance regarding Control of Nitrosamine Impurities in Human Drugs
What’s new?
Quality Assurance
27 Jan 2025
New revision to EMA Guidance documents released
Both documents, Guidance on the procedural aspects for the consultation to the European Medicines...
Quality Assurance
9 Jul 2024
New Update of Appendix 1 of the Nitrosamines Guideline
What’s new? In this update, the Acceptable Intake (AI) values for nitrosamines related to the use...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe